Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
about
Treatment of Erdheim-Chester disease with cladribine: a rational approachRevisiting the role of cladribine in acute myeloid leukemia: an improvement on past accomplishments or more old news?Pulmonary langerhans cell histiocytosisCladribine Exposure Results in a Sustained Modulation of the Cytokine Response in Human Peripheral Blood Mononuclear CellsChronic myelomonocytic leukemia coexisting with B-cell chronic lymphocytic leukemia.Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemia.Effectiveness of cladribine therapy in patients with pulmonary Langerhans cell histiocytosis.Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remissionSolitary plasmacytoma in the setting of Langerhans cell histiocytosis.Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosineCombination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trialRelapsed and refractory pediatric acute myeloid leukemia: current and emerging treatments.Treatment options--commentary.Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.2 chlorodeoxyadenosine activity and cross resistance patterns in primary cultures of human hematologic neoplasms.Cladribine (2-chlorodeoxyadenosine) in frontline chemotherapy for adult Langerhans cell histiocytosis: A single-center study of seven cases.Gynecomastia in a case of hairy cell leukaemia--cladribine induced?Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine.Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A.2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.Lessons to be learned--Langerhans' cell histiocytosis.Successful treatment of histiocytic sarcoma with cladribine and high-dose cytosine arabinoside in a child.2-Chlorodeoxyadenosine (cladribine) induces apoptosis in human monocyte-derived dendritic cells.Streptococcus suis synthesizes deoxyadenosine and adenosine by 5'-nucleotidase to dampen host immune responses
P2860
Q24670811-A06DFDB4-3761-463B-B71F-7301E8F4ACC3Q26860830-D5CA611B-444B-422A-B075-511B276D8414Q26999512-B8143F82-E206-4B57-B2E8-0B4B71540D15Q28548449-E1209337-4DCC-4D6B-9E01-AC053E2B5A60Q33358668-A062476D-FFA6-4D8B-A755-756DA81995DDQ34062534-06779D12-0D38-41BB-B590-48D99CDC4324Q34721008-45EEAB22-E0E4-4B4F-A50F-6F7E44F61189Q35609790-D4106B5B-D585-4D31-A4B6-F23F137D3D4FQ35670989-3A1D02F7-8605-4E01-86A7-D2B0C7107D60Q36931065-41CF9780-A0F6-4AD8-B233-F49BF859FC1BQ37303824-CAD51BCD-CC6E-4AF7-B2F3-43C0127730B8Q38155455-897CC45F-EC9C-4D4E-BC88-F813BA4CDCEAQ40696534-9646E625-2117-4F6B-AE01-D1848A69545BQ41643072-98275E53-68EB-4E61-B1C3-5A684D8D98BCQ42390436-B525ABDD-B074-4898-A1D5-46805EDE40B0Q43425045-F16D32E1-4CF2-4C6E-8736-22AA2C52B3C7Q43792729-B7C0B640-1C25-4FF4-8ABB-BD72D0338983Q43916589-421F9CEF-AD1C-4F7F-A00F-0008AD4CDE03Q44475349-50DCECA9-E24E-4E84-B2C9-97A509376201Q46122059-D7154A14-8B8F-47E2-A7F6-D42AA9FDE6B7Q46754470-E1282393-35E8-4E21-BDF6-576E49F1C4D1Q48182208-6C00E3B4-7A2D-40B3-AE1E-82278F3849C0Q51052730-2696E644-71DB-4E30-B84D-C3427DF749FBQ58735459-17D73012-82ED-46E1-AC8C-2B39E333165A
P2860
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy.
description
1990 nî lūn-bûn
@nan
1990 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@ast
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@en
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@nl
type
label
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@ast
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@en
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@nl
prefLabel
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@ast
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@en
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@nl
P2093
P2860
P356
P1476
Potent toxicity of 2-chlorodeo ...... to immunosuppressive therapy.
@en
P2093
C J Carrera
D A Carson
P2860
P304
P356
10.1172/JCI114865
P407
P577
1990-11-01T00:00:00Z